清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction

医学 内科学 肝细胞癌 倾向得分匹配 阿替唑单抗 无容量 贝伐单抗 回顾性队列研究 危险系数 胃肠病学 癌症 肿瘤科 置信区间 免疫疗法 化疗
作者
Claudia Angela Maria Fulgenzi,Bernhard Scheiner,Antonio D’Alessio,Aman Mehan,Giulia Francesca Manfredi,Ciro Celsa,Naoshi Nishida,Celina Ang,Thomas Urban Marron,Linda Y. Wu,Anwaar Saeed,Brooke Wietharn,Antonella Cammarota,Tiziana Pressiani,Matthias Pinter,Rohini Sharma,Jaekyung Cheon,Yi‐Hsiang Huang,Pei‐Chang Lee,Samuel Phen
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:10 (9): 1253-1253 被引量:44
标识
DOI:10.1001/jamaoncol.2024.2166
摘要

Importance: Whether patients with Child-Pugh class B (CP-B) cancer with unresectable hepatocellular carcinoma (uHCC) benefit from active anticancer treatment vs best supportive care (BSC) is debated. Objective: To evaluate the association of immune checkpoint inhibitor (ICI)-based therapies vs BSC with overall survival (OS) of patients with uHCC and CP-B liver dysfunction. Design, Setting, and Participants: This retrospective, multicenter, international clinical case series examined data of patients with CP-B with uHCC who were receiving first-line ICI-based regimens from September 2017 to December 2022 whose data were extracted from an international consortium and compared with a cohort of patients with CP-B receiving BSC. Patients were treated in tertiary care centers across Europe, US, and Asia in routine clinical practice. After applying the inclusion criteria, 187 and 156 patients were left in the ICI and BSC groups, respectively. The propensity score was calculated for the following variables: age, alpha-fetoprotein levels, Child-Pugh score, extrahepatic spread, portal vein tumor thrombosis, cirrhosis, ascites, and baseline Eastern Cooperative Oncology Group performance status. Exposures: Patients in the ICI group received first-line systemic therapy with either atezolizumab plus bevacizumab (A+B) (n = 141) or nivolumab (n = 46). Main Outcomes and Measures: OS in the inverse probability of treatment weighting (IPTW) populations was the main outcome, and it was estimated with Kaplan-Meier method; univariable Cox regression test was used to make comparisons between the 2 groups. Results: The median age was 66 (IQR, 61-72) and 73 (IQR, 66-81) years in the ICI (33 women [18%]) and BSC groups (41 women [26%]), respectively. In the IPTW populations, median OS was significantly longer in the ICI group (7.50 months; 95% CI, 5.62-11.15) compared with BSC (4.04 months; 95% CI, 3.03-5.03; hazard ratio, 0.59; 95% CI, 0.43-0.80; P < .001). Multivariable analysis confirmed that ICI exposure was associated with a reduction of approximately 50% in the risk of death (hazard ratio, 0.55; 95% CI, 0.35-0.86; P < .001), and the presence of portal vein tumor thrombosis, an Eastern Cooperative Oncology Group performance score of greater than 1, and alpha-fetoprotein levels of 400 ng/mL or greater were associated with increased risk of death. Conclusions and Relevance: The results of this case series provide comparative evidence of improved survival in association with ICI treatment compared with BSC in patients with uHCC with CP-B liver dysfunction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
优美涵柏完成签到,获得积分10
2秒前
小巧如音完成签到,获得积分10
15秒前
思源的应助被科研通管家采纳,获得10
25秒前
25秒前
结实的易真完成签到,获得积分10
31秒前
丰富的从雪完成签到,获得积分10
45秒前
51秒前
踏实的雁兰完成签到,获得积分10
53秒前
精明夜安完成签到,获得积分10
54秒前
大方的钥匙完成签到,获得积分10
1分钟前
bluemoon完成签到,获得积分20
1分钟前
Orange的应助被好德小饼干采纳,获得10
1分钟前
听话的尔竹完成签到,获得积分10
1分钟前
1分钟前
1分钟前
bluemoon发布了新的文献求助10
1分钟前
无极微光的应助被王磊磊0811采纳,获得20
1分钟前
1分钟前
灵巧笑旋完成签到,获得积分10
1分钟前
拼搏静槐完成签到,获得积分10
1分钟前
传奇3的应助被好德小饼干采纳,获得10
1分钟前
超帅晓槐完成签到,获得积分10
1分钟前
2分钟前
无辜秋尽完成签到,获得积分10
2分钟前
自信的镜子完成签到,获得积分10
2分钟前
Hello的应助被科研通管家采纳,获得10
2分钟前
脑洞疼的应助被科研通管家采纳,获得10
2分钟前
SciGPT的应助被科研通管家采纳,获得10
2分钟前
车厘子完成签到,获得积分10
2分钟前
阔达翠霜完成签到,获得积分10
2分钟前
隐形的芷文完成签到,获得积分10
2分钟前
开心的筮完成签到,获得积分10
3分钟前
能干念波完成签到 ,获得积分10
3分钟前
秀丽颤完成签到,获得积分10
3分钟前
迷路芷荷完成签到,获得积分10
3分钟前
披着羊皮的狼完成签到 ,获得积分0
3分钟前
虚心从蓉完成签到,获得积分10
3分钟前
mtenxx完成签到,获得积分10
3分钟前
懦弱的绿蝶完成签到,获得积分10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158935
求助须知:如何正确求助?哪些是违规求助? 9554526
关于积分的说明 21719385
捐赠科研通 7748467
什么是DOI,文献DOI怎么找? 3427107
关于科研通互助平台的介绍 2552013
邀请新用户注册赠送积分活动 2471370